Solifenacin significantly improves all symptoms of overactive bladder syndromeCHAPPLE, C. R; CARDOZO, L; STEERS, W. D et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 8, pp 959-966, issn 1368-5031, 8 p.Article

Treatment outcomes in the STAR study : A subanalysis of solifenacin 5 mg and tolterodine ER 4 mgCHAPPLE, Christopher R; FIANU-JONSSON, Aino; INDIG, Mark et al.European urology. 2007, Vol 52, Num 4, pp 1195-1203, issn 0302-2838, 9 p.Article

Improved quality of life in patients with overactive bladder symptoms treated with solifenacinKELLEHER, Con J; CARDOZO, Linda; CHAPPLE, Christopher R et al.BJU international (Papier). 2005, Vol 95, Num 1, pp 81-85, issn 1464-4096, 5 p.Article

Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometryMACEK, Jan; PTACEK, Pavel; KLIMA, Josef et al.Journal of chromatography. B. 2010, Vol 878, Num 31, pp 3327-3330, issn 1570-0232, 4 p.Article

Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatographyYANAGIHARA, Takamitsu; AOKI, Toshiko; SOEISHI, Yoshiaki et al.Journal of chromatography. B. 2007, Vol 859, Num 2, pp 241-245, issn 1570-0232, 5 p.Article

Solifenacin for overactive bladder with incontinence : Symptom bother and health-related quality of life outcomesGARELY, Alan D; LUCENTE, Vincent; VAPNEK, Jonathan et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 391-399, issn 1060-0280, 9 p.Article

Solifenacin is effective for thetreatment of OAB dry patients : A pooled analysisABRAMS, Paul; SWIFT, Steven.European urology. 2005, Vol 48, Num 3, pp 483-487, issn 0302-2838, 5 p.Article

Redefining response in overactive bladder syndromePAYNE, Christopher K; KELLEHER, Con.BJU international (Papier). 2007, Vol 99, Num 1, pp 101-106, issn 1464-4096, 6 p.Article

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in ratsOHTAKE, Akiyoshi; UKAI, Masashi; HATANAKA, Toshiki et al.European journal of pharmacology. 2004, Vol 492, Num 2-3, pp 243-250, issn 0014-2999, 8 p.Article

Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder : The VESIcare open-label trial (VOLT)GARELY, Alan D; KAUFMAN, Joel M; SAND, Peter K et al.Clinical therapeutics. 2006, Vol 28, Num 11, pp 1935-1946, issn 0149-2918, 12 p.Article

Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use : A 12-Week, Open-Label, Post-Marketing Surveillance StudyMICHEL, Martin C; WETTERAUER, Ulrich; VOGEL, Monika et al.Drug safety. 2008, Vol 31, Num 6, pp 505-514, issn 0114-5916, 10 p.Article

Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteersSWART, Pieter J; KRAUWINKEL, Walter J. J; SMULDERS, Ronald A et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 1, pp 33-36, issn 1742-7835, 4 p.Article

A Validated Rapid Stability-Indicating Method for the Determination of Related Substances in Solifenacin Succinate by Ultra-Fast Liquid ChromatographyKRISHNA, S. Radha; RAO, B. M; SOMESWARA RAO, N et al.Journal of chromatographic science. 2010, Vol 48, Num 10, pp 807-810, issn 0021-9665, 4 p.Article

Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in miceOKI, Tomomi; SATO, Shuichi; MIYATA, Keiji et al.British journal of pharmacology. 2005, Vol 145, Num 2, pp 219-227, issn 0007-1188, 9 p.Article

Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndromeABRAMS, Paul; CHAPPLE, Christopher R; JÜNEMANN, Klaus-Peter et al.World journal of urology (Print). 2012, Vol 30, Num 3, pp 385-392, issn 0724-4983, 8 p.Article

Solifenacin in the treatment of urgency and other symptoms of overactive bladder : results from a randomized, double-blind, placebo-controlled, rising-dose trialCARDOZO, Linda; HESSDÖRFER, Elke; MILANI, Rodolfo et al.BJU international (Papier). 2008, Vol 102, Num 9, pp 1120-1127, issn 1464-4096, 8 p.Article

Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE)CARDOZO, Linda; AMARENCO, Gerard; PUSHKAR, Dmitry et al.BJU international (Papier). 2013, Vol 111, Num 5, pp 804-810, issn 1464-4096, 7 p.Article

A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome : Results of the STAR trialCHAPPLE, C. R; MARTINEZ-GARCIA, R; SELVAGGI, L et al.European urology. 2005, Vol 48, Num 3, pp 464-470, issn 0302-2838, 7 p.Article

Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women : A double-blind, placebo-controlled studyTAEKEMA-ROELVINK, Miriam E. J; SWART, Pietj; KUIPERS, Mirjam E et al.Clinical therapeutics. 2005, Vol 27, Num 9, pp 1403-1410, issn 0149-2918, 8 p.Article

Food does not affect the pharmacokinetics of solifenacin, a new muscarinic receptor antagonist: results of a randomized crossover trialUCHIDA, Taisuke; KRAUWINKEL, Walter J; MULDER, Hans et al.British journal of clinical pharmacology. 2004, Vol 58, Num 1, pp 4-7, issn 0306-5251, 4 p.Article

Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceWAGG, Adrian; COMPION, Gerhard; FAHEY, Amanda et al.BJU international (Papier). 2012, Vol 110, Num 11, pp 1767-1774, issn 1464-4096, 8 p.Article

Solifenacin succinate for the treatment of symptoms of overactive bladderMANISCALCO, Maria; SINGH-FRANCO, Devada; WOLOWICH, William R et al.Clinical therapeutics. 2006, Vol 28, Num 9, pp 1247-1272, issn 0149-2918, 26 p.Article

Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout miceITO, Yoshihiko; OYUNZUL, Luvsandorj; YAMADA, Shizuo et al.European journal of pharmacology. 2009, Vol 615, Num 1-3, pp 201-206, issn 0014-2999, 6 p.Article

Muscarinic receptors in the bladder : from basic research to therapeuticsHEGDE, Sharath S.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S80-S87, SUP2Conference Paper

Persistence with antimuscarinic therapy in patients with overactive bladderHAAB, F; CASTRO-DIAZ, D.International journal of clinical practice (Esher). 2005, Vol 59, Num 8, pp 931-937, issn 1368-5031, 7 p.Article